Home > Insider Trading > Ophthalix, Inc. > Profile

Ophthalix, Inc. (OPLI)

Sector: Pharmaceutical Preparations

Related Insiders

Ltd. Biopharma Can-Fite, Large Shareholder, 2013-05-14
Itay Weinstein, Chief Financial Officer, 2013-05-13
Barak Singer, Chief Executive Officer, 2013-05-08

Ltd. Biopharma Can-Fite, Large Shareholder, 2013-05-14
Itay Weinstein, Chief Financial Officer, 2013-05-13
Barak Singer, Chief Executive Officer, 2013-05-08
Gil Ben-Menachem, Chief Executive Officer, 2013-01-08
Guy Regev, Director, 2012-03-20
Pnina Fishman, Interim Ceo, 2011-12-01
Ilan Cohn, Director, 2011-12-01
Matthew Rule, Other, 2011-11-23

Show All Insiders (8)

Insider Trading: Purchases See All

Insider	Price	Amount	Relationship	Remaning Holdings	Date	Form 4
Regev	$63,677.00	32,072	Director	255,535	2012-03-18	Filing

Insider Trading: Sales See All

Insider	Price	Amount	Relationship	Remaining Holdings	Date	Form 4
Rule	$7,750.00	7,750,000	Other	250,000	2011-11-21	Filing

Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 20 percentage points in 6 months - Learn how!

Hedge Fund Resource Center

Billionaire Hedge Funds